The acquisition provides GSK access to Camlipixant, a P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC.
Creagh Milford, DO, MPH, senior vice president of retail health at CVS Health, spoke to DSN about the platform and how it works to help transform the way health care is delivered.
The Alliance for Long-Term Care Pharmacy @ Home is a collaborative effort that aims to improve the care provided to individuals with complex medical needs living in the community.